【上海医药：硝酸异山梨酯注射液通过仿制药一致性评价】上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。

金融界01-02

上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2500905912?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-02 16:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500905912","market":"hk","top_or_hot":-1,"title":"【上海医药：硝酸异山梨酯注射液通过仿制药一致性评价】上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。","media":"金融界","content":"<html><body><div><span><a href=\"https://laohu8.com/S/601607\">上海医药</a></span>公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。</div></body></html>","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【上海医药：硝酸异山梨酯注射液通过仿制药一致性评价】上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【上海医药：硝酸异山梨酯注射液通过仿制药一致性评价】上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">金融界</strong><span class=\"h-time small\">2025-01-02 16:54</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><div><span><a href=\"https://laohu8.com/S/601607\">上海医药</a></span>公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://24h.jrj.com.cn/2025/01/02165447039981.shtml\">金融界</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/01/02165447039981.shtml","article_id":"2500905912","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500905912","pubTimestamp":1735808054,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601607":"上海医药","BK0175":"白马股","BK0097":"医药电商","BK0099":"上海本地重组","BK0196":"行业龙头","BK0020":"浦东新区","02607":"上海医药","BK0028":"国家队","BK0184":"上海国资改革","BK0209":"零售","BK0188":"融资融券","BK1197":"保健护理产品经销商","BK0183":"MSCI概念","BK0187":"一线龙头","BK0012":"证金概念"},"translate_title":"[Shanghai Pharmaceuticals: Isosorbide dinitrate injection passed the consistency evaluation of generic drugs] Shanghai Pharmaceuticals announced that the isosorbide dinitrate injection of Shanghai Pharmaceuticals First Biochemical Pharmaceutical Co., Ltd., a wholly-owned subsidiary, passed the consistency evaluation of generic drug quality and efficacy. The drug is mainly used for the treatment of unstable angina pectoris, and the hospital purchase amount in 2023 will be 907 million yuan. Evaluation is conducive to expanding market share and enhancing competitiveness, but due to the influence ","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"上海医药公告，全资子公司上药第一生化药业有限公司的硝酸异山梨酯注射液通过仿制药质量和疗效一致性评价。该药品主要用于不稳定性心绞痛等治疗，2023年医院采购金额为9.07亿元。通过评价有利于扩大市场份额，提升竞争力，但受政策、市场环境影响，销售存在不确定性。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2500905912"}